Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Periodontal Treatment Reduces Circulating Pro-Inflammatory Cytokine and Chemokine Levels in African American HIV+ Individuals with Virological Suppression.

Journal of dental applications·2022
Same author

Management of well appearing infants born to afebrile mothers with inadequate GBS prophylaxis: A retrospective comparison of the three approaches recommended by the COFN.

Journal of neonatal-perinatal medicine·2021
Same author

Distinct Microbial Signatures between Periodontal Profile Classes.

Journal of dental research·2021
Same author

Gender Inequalities in the Dental Workforce: Global Perspectives.

Advances in dental research·2019
Same author

The Association between the History of HIV Diagnosis and Oral Health.

Journal of dental research·2016
Same author

Impact of periodontal intervention on local inflammation, periodontitis, and HIV outcomes.

Oral diseases·2016

Related Experiment Video

Updated: Mar 22, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.1K

Hairy leukoplakia; lessons learned: 30-plus years.

J S Greenspan1, D Greenspan1, J Webster-Cyriaque2

  • 1Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA, USA.

Oral Diseases
|April 26, 2016
PubMed
Summary
This summary is machine-generated.

Oral hairy leukoplakia (HL), initially linked to HIV/AIDS, is now understood to affect individuals beyond the HIV spectrum. Its association with Epstein-Barr virus (EBV) and management are key considerations.

Keywords:
Epstein-Barr virusHIV/AIDShairy leukoplakiaoral lesions

More Related Videos

Plaquing of Herpes Simplex Viruses
04:41

Plaquing of Herpes Simplex Viruses

Published on: November 5, 2021

7.3K
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
07:26

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes

Published on: February 22, 2012

19.9K

Related Experiment Videos

Last Updated: Mar 22, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

13.1K
Plaquing of Herpes Simplex Viruses
04:41

Plaquing of Herpes Simplex Viruses

Published on: November 5, 2021

7.3K
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
07:26

Generation of Organotypic Raft Cultures from Primary Human Keratinocytes

Published on: February 22, 2012

19.9K

Area of Science:

  • Oral medicine
  • Virology
  • Immunology

Background:

  • The HIV/AIDS pandemic has revealed numerous oral manifestations.
  • Oral hairy leukoplakia (HL) is a significant oral lesion associated with Epstein-Barr virus (EBV).
  • Initially observed primarily in individuals with HIV/AIDS, HL's prevalence is now recognized to extend beyond this population.

Purpose of the Study:

  • To review the clinical and histological features of oral hairy leukoplakia (HL).
  • To explore the discovery, cause, diagnosis, and pathogenesis of HL.
  • To discuss the relationship between HL, HIV/AIDS, Epstein-Barr virus (EBV) biology, and the impact of HIV/AIDS therapy.

Main Methods:

  • Literature review of clinical and histological data on oral hairy leukoplakia.
  • Analysis of the association between HL, Epstein-Barr virus (EBV), and HIV/AIDS.
  • Examination of diagnostic criteria and management strategies for HL.

Main Results:

  • Oral hairy leukoplakia (HL) is an Epstein-Barr virus (EBV)-associated oral lesion.
  • HL is not exclusive to individuals with HIV/AIDS, with a broader distribution observed.
  • Understanding HL's pathogenesis and its changes with HIV/AIDS therapy is crucial.

Conclusions:

  • Oral hairy leukoplakia (HL) is an important oral manifestation linked to Epstein-Barr virus (EBV).
  • The scope of HL extends beyond the HIV/AIDS spectrum.
  • Further research into HL's pathogenesis and management, especially in the context of evolving HIV/AIDS therapies, is warranted.